Andrew Christiansen - 22 Mar 2023 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role: Chief Financial Officer
Signature: /s/ Jason Minio, Attorney-in-Fact
Issuer symbol: CDLX
Transactions as of: 22 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 04 Apr 2023, 16:10:04 UTC
Previous filing: 13 Jan 2023
Next filing: 03 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDLX	Common Stock	Options Exercise	$0	+8,136	+26%	$0.000000	39,561	22 Mar 2023	Direct	F1
transaction	CDLX	Common Stock	Options Exercise	$0	+9,677	+24%	$0.000000	49,238	01 Apr 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDLX	Restricted Stock Units	Options Exercise	$0	-8,136	-25%	$0.000000	24,411	22 Mar 2023	Common Stock	8,136		Direct	F2, F3
transaction	CDLX	Restricted Stock Units	Options Exercise	$0	-9,677	-50%	$0.000000	9,677	01 Apr 2023	Common Stock	9,677		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
F2	Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F3	The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.